Publications by Type
24 found
Show per page
Peer-Reviewed Publication Types
The Lancet Global Health, 12(8), e1312–e1322. https://doi.org/10.1016/s2214-109x(24)00183-9
, Ringera, Isaac Kaumbuthu, Luoga, Ezekiel, Bresser, Moniek, Mothobi, Buoang, Kabundi, Lorraine, Ilunga, Mulume, Mokhele, Kuena, Isaac, Andreas Boy, Tsoaeli, Ntsepiseng, Mbaya, Thomas, Simba, Brenda, Mayogu, Kasasi, Mabula, Elizabeth, Cheleboi, Molisana, Molatelle, Mamello, Kimera, Namvua, Mollel, Getrud Joseph, Sando, David, et al. (2024). Resistance-informed versus empirical management of viraemia in children and adolescents with HIV in Lesotho and Tanzania (GIVE MOVE trial): a multisite, open-label randomised controlled trial [Journal-article]. Tschumi, Nadine, Lukau, Blaise, Tlali, Katleho, Motaboli, Lipontso, Kao, Mpho, Kopo, Mathebe, Hänggi, Kathrin, Mokebe, Moleboheng, Naegele, Klaudia, Ayakaka, Irene, Leuzinger, Karoline, Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae185
, & Labhardt, Niklaus D. (2024). Emergence of acquired dolutegravir resistance in treatment-experienced people with HIV in Lesotho [Journal-article]. Devendra, Akash, Kohler, Maurus, Letsika, Motlatsi, Khooa, Hape, Motaboli, Lipontso, Lerotholi, Malebanye, Tschumi, Nadine, Labhardt, Niklaus D., & AIDS (London, England), 38, 1013–1023. https://doi.org/10.1097/qad.0000000000003835
(2024). HIV viral suppression in children and adolescents 2 years after transition to dolutegravir: a multicentre cohort study [Journal-article]. Kohler, Maurus, Open Forum Infectious Diseases, 11. https://doi.org/10.1093/ofid/ofae013
, Tschumi, Nadine, Lerotholi, Malebanye, Motaboli, Lipontso, Mokete, Moliehi, Chammartin, Frédérique, & Labhardt, Niklaus D. (2024). Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data From the Viral Load Cohort North-East Lesotho (VICONEL). The Journal of Infectious Diseases, 228(8), 1042–1054. https://doi.org/10.1093/infdis/jiad197
, Hauser A, Abela IA, Pasin C, Epp S, Mohloanyane T, Nsakala BL, Trkola A, Labhardt ND, Kouyos RD, & Günthard HF. (2023). Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity. Labhardt ND, Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 77(8), 1176–1184. https://doi.org/10.1093/cid/ciad317
, Sass N, Ford N, & Rosen S. (2023). Treatment Outcomes After Offering Same-Day Initiation of Human Immunodeficiency Virus Treatment-How to Interpret Discrepancies Between Different Studies. Tschumi N, Lerotholi M, Motaboli L, Mokete M, Labhardt ND, & Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciad390
. (2023). Two-year outcomes of treatment-experienced adults after programmatic transitioning to dolutegravir: longitudinal data from the VICONEL HIV cohort in Lesotho. HIV medicine, 23(3), 287–293. https://doi.org/10.1111/hiv.13189
, Nsakala, Bienvenu L., Mokhele, Kuena, Rakuoane, Itumeleng, Muhairwe, Josephine, Urda, Lorena, Amstutz, Alain, Tschumi , Nadine, Klimkait, Thomas, & Labhardt, Niklaus D. (2022). Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: a prospective cohort study in Lesotho (DO-REAL study). Jawaid A, Diabetes mellitus in amyotrophic lateral sclerosis: Dr. Jekyll or Mr. Hyde? (Patent No. 11). 22(11), Article 11. https://doi.org/10.1111/ene.12660
, & Schulz PE. (2015). Other Publications
Cohort profile: the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2022 - cohort description, test volumes, predictors of viraemia, and the road ahead [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2024.03.12.24304025
, Motaboli, Lipontso, Lerotholi, Malebanye, Kohler, Maurus, Hänggi, Kathrin, Mokete, Moliehi, Chakely, Makobefo G., Kao, Mpho, Kopo, Mathebe, Mokebe, Moleboheng, Nsakala, Bienvenu L., Lukau, Blaise, Ayakaka, Irene, Amstutz, Alain, Ehmer, Jochen, Klimkait, Thomas, Glass, Tracy R., Muhairwe, Josephine, Chammartin, Frédérique, et al. (2024). Tschumi, Nadine, Lukau, Blaise, Tlali, Katleho, Motaboli, Lipontso, Kao, Mpho, Kopo, Mathebe, Hänggi, Kathrin, Mokebe, Moleboheng, Naegele, Klaudia, Ayakaka, Irene, Leuzinger, Karoline, Emergence of Acquired Dolutegravir Resistance in Treatment-Experienced People with HIV in Lesotho [Posted-content]. Elsevier BV. https://doi.org/10.2139/ssrn.4683840
, & Labhardt, Niklaus Daniel. (2024). Kopo, M., Lejone, T. I., Tschumi, N., Glass, T. R., Kao, M., PLoS Med, 20(1), e1004150. https://doi.org/10.1371/journal.pmed.1004150
, Seiler, O., Muhairwe, J., Moletsane, N., Labhardt, N. D., & Amstutz, A. (2023). Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: the PEBRA cluster-randomized trial. Seiler, O., Kopo, M., Kao, M., Lejone, T. I., Tschumi, N., Glass, T. G., AIDS Res Treat, 2023, 8124192. https://doi.org/10.1155/2023/8124192
, Labhardt, N. D., & Amstutz, A. (2023). HIV care preferences among young people living with HIV in Lesotho: a secondary data analysis of the PEBRA cluster randomized trial. Seiler, O., Kopo, M., Kao, M., Lejone, T. I., Tschumi, N., Glass, T. R., Brown, J. A., Labhardt, N. D., & Amstutz, A. (2022). HIV care preferences among young people living with HIV in Lesotho: A secondary data analysis of the PEBRA cluster randomized trial [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.07.29.22278205
HIV Med, 24(2), 153–162. https://doi.org/10.1111/hiv.13352
, Nsakala, B. L., Mokhele, K., Rakuoane, I., Muhairwe, J., Glass, T. R., Amstutz, A., Tschumi, N., Belus, J. M., Klimkait, T., & Labhardt, N. D. (2022). Dolutegravir in real life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho. Kopo, M., Lejone, T. I., Tschumi, N., Glass, T. R., Kao, M., Brown, J. A., Seiler, O., Muhairwe, J., Moletsane, N., Labhardt, N. D., & Amstutz, A. (2022). Effectiveness of a Peer Educator-Coordinated Preference-Based Differentiated Delivery Model on Viral Suppression Among Young People Living with HIV in Lesotho: The PEBRA Cluster Randomized Trial [Journal-article]. In SSRN Electronic Journal. https://doi.org/10.2139/ssrn.4019324
Muhairwe, J. A., Pediatr Infect Dis J, 41(3), e75–e80. https://doi.org/10.1097/inf.0000000000003415
, Motaboli, L., Nsakala, B. L., Lerotholi, M., Amstutz, A., Klimkait, T., Glass, T. R., & Labhardt, N. D. (2022). The suboptimal pediatric HIV viral load cascade: multidistrict cohort study among children taking antiretroviral therapy in Lesotho, Southern Africa. Tschumi, N., Lerotholi, M., Kopo, M., Kao, M., Lukau, B., Nsakala, B., Chejane, N., Motaboli, L., Lee, T., Barnabas, R., Shapiro, A. E., van Heerden, A., Lejone, T. I., Amstutz, A., PLoS One, 17(5), e0268100. https://doi.org/10.1371/journal.pone.0268100
, Heitner, J., Belus, J. M., Chammartin, F., & Labhardt, N. D. (2022). Assessment of a viral load result-triggered automated differentiated service delivery model for people taking ART in Lesotho (the VITAL study): study protocol of a cluster-randomized trial. The Journal of Antimicrobial Chemotherapy, 76(5), 1294–1298. https://doi.org/10.1093/jac/dkab025
, Amstutz, A., Nsakala, B. L., Seeburg, U., Vanobberghen, F., Muhairwe, J., Klimkait, T., Daniel Labhardt, N., & Daniel Labhardt, N. (2021). Extensive drug resistance during low-level HIV viraemia while taking NNRTI-based ART supports lowering the viral load threshold for regimen switch in resource-limited settings: a pre-planned analysis from the SESOTHO trial. Open Forum Infect Dis, 8(5), ofab046. https://doi.org/10.1093/ofid/ofab046
, Mbunkah, H. A., Lejone, T. I., Ringera, I., Cheleboi, M., Klimkait, T., Metzner, K. J., Gunthard, H. F., Labhardt, N. D., Kouyos, R. D., & Tschumi, N. (2021). Emergence of human immunodeficiency virus-1 drug resistance during the 3-month World Health Organization-recommended enhanced adherence counseling period in the CART-1 cohort study. BMC infectious diseases, 20(1), 773. https://doi.org/10.1186/s12879-020-05491-9
, Ringera, Isaac, Luoga, Ezekiel, Cheleboi, Molisana, Kimera, Namvua, Muhairwe, Josephine, Kayembe, Buntshi Paulin, Molapo Hlasoa, Mosa, Kabundi, Lorraine, Yav, Ching Wey David, Mothobi, Buoang, Thahane, Lineo, Amstutz, Alain, Bachmann, Nadine, Mollel, Getrud Joseph, Bresser, Moniek, Glass, Tracy Renée, Paris, Daniel Henry, Klimkait, Thomas, et al. (2020). Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania. Lejone, Thabo Ishmael, Kopo, Mathebe, Bachmann, Nadine, BMC Public Health, 20(1), 425. https://doi.org/10.1186/s12889-020-08535-6
, Glass, Tracy Renée, Muhairwe, Josephine, Matsela, Tebatso, Scherrer, Ramona, Chere, Lebohang, Namane, Tilo, Labhardt, Niklaus Daniel, & Amstutz, Alain. (2020). PEBRA trial - effect of a peer-educator coordinated preference-based ART service delivery model on viral suppression among adolescents and young adults living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho. Amstutz, Alain, Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 71(10), 2608–2614. https://doi.org/10.1093/cid/ciz1126
, Ringera, Isaac, Muhairwe, Josephine, Lejone, Thabo Ishmael, Klimkait, Thomas, Glass, Tracy Renée, & Labhardt, Niklaus Daniel. (2019). Engagement in care, viral suppression, drug resistance and reasons for non-engagement after home-based same-day ART initiation in Lesotho: a two-year follow-up of the CASCADE trial. Courlet, Perrine, Decosterd, Laurent Arthur, Journal of Antimicrobial Chemotherapy, 74(8), 2468–2470. https://doi.org/10.1093/jac/dkz181
, Alves Saldanha, Susana, Marzolini, Catia, Cavassini, Matthias, Stoeckle, Marcel, Csajka, Chantal, Labhardt, Niklaus Daniel, Calmy, Alexandra, & Swiss HIV Cohort Study,. (2019). Emtricitabine and lamivudine concentrations in saliva : a simple suitable test for treatment adherence.